Posted by admin on Aug 19th, 2022

Globus Medical (NYSE:GMED – Get Rating) and Tactile Systems Technology (NASDAQ:TCMD – Get Rating) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, institutional ownership, valuation and profitability.

Globus Medical has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Comparatively, Tactile Systems Technology has a beta of 1.5, indicating that its share price is 50% more volatile than the S&P 500.

This table compares Globus Medical and Tactile Systems Technology’s revenue, earnings per share and valuation.

Globus Medical has higher revenue and earnings than Tactile Systems Technology. Tactile Systems Technology is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

This table compares Globus Medical and Tactile Systems Technology’s net margins, return on equity and return on assets.

67.2% of Globus Medical shares are held by institutional investors. Comparatively, 92.6% of Tactile Systems Technology shares are held by institutional investors. 24.4% of Globus Medical shares are held by insiders. Comparatively, 3.3% of Tactile Systems Technology shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

This is a summary of recent recommendations for Globus Medical and Tactile Systems Technology, as provided by MarketBeat.com.

Globus Medical presently has a consensus target price of $77.36, suggesting a potential upside of 16.83%. Tactile Systems Technology has a consensus target price of $23.33, suggesting a potential upside of 124.14%. Given Tactile Systems Technology’s stronger consensus rating and higher possible upside, analysts clearly believe Tactile Systems Technology is more favorable than Globus Medical.

Globus Medical beats Tactile Systems Technology on 10 of the 14 factors compared between the two stocks.

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Receive News & Ratings for Globus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globus Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Q3 2022 EPS Estimates for Auto Prop Reit Cut by Analyst (TSE:APR)

Osisko Gold Royalties (TSE:OR) PT Raised to C$19.00 at BMO Capital Markets